首页> 外国专利> Use of agents that prevent generation of amyloid and amyloid-like lipoproteins, and/or use of agents that promote sequestration and/or degradation of, and/or prevent neurotoxicity of such proteins in the treatment of hearing loss and improving body balance

Use of agents that prevent generation of amyloid and amyloid-like lipoproteins, and/or use of agents that promote sequestration and/or degradation of, and/or prevent neurotoxicity of such proteins in the treatment of hearing loss and improving body balance

机译：在治疗听力损失和改善身体平衡中使用防止淀粉样蛋白和淀粉样蛋白样脂蛋白产生的试剂，和/或促进这类蛋白的螯合和/或降解和/或预防此类蛋白的神经毒性的试剂的使用

页面导航

摘要
著录项
相似文献

摘要

The present invention provides compositions and methods for treating otic disorders. More specifically, the present invention describes the use of agents that down-regulate expression of Tanis and/or p21^{Waf1/Cip1/Sd1}genes to treat such disorders of the ear.

机译：本发明提供了治疗耳部疾病的组合物和方法。更具体地说，本发明描述了下调Tanis和/或p21 基因表达的药物在治疗这种耳朵疾病中的用途。

著录项

公开/公告号US2005137122A1

专利类型
公开/公告日2005-06-23

原文格式PDF
申请/专利权人 NAJAM A. SHARIF;
展开▼

申请/专利号US20040005923
发明设计人 NAJAM A. SHARIF;
展开▼

申请日2004-12-07
分类号A61K38/17;A61K31/7076;A61K31/553;A61K31/353;A61K31/20;
国家 US
入库时间 2022-08-21 22:24:06

相似文献

专利
外文文献
中文文献